← Open Payments lookup

DANIEL TOUSSAINT: Open Payments

NPI 1770113011 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$886 in 32 payments from 10 companies in 2025. Trend: 2023 $510 · 2024 $993 · 2025 $886

Food & beverage: $886
CompanyPaymentsAmount
Lilly USA, LLC6$206
Novo Nordisk Inc6$187
GlaxoSmithKline, LLC.4$166
PFIZER INC.6$150
Amgen Inc.4$59
Merck Sharp & Dohme LLC2$44
Dynavax Technologies Corporation1$22
IBSA Pharma Inc.1$20
Exact Sciences Corporation1$15
AstraZeneca Pharmaceuticals LP1$15

Products named: Ozempic, AREXVY, ZEPBOUND, NURTEC ODT, MOUNJARO, SHINGRIX, OTEZLA, PREVNAR 20.

Industry payments across TX — which companies pay providers there.